| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 60.11M | — |
| Operating expense | — | — |
| Net income | -56.74M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, RYTM returned +6.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +2.8% |
| 1 year | +6.5% |
| 5 years | +745.5% |
| All-time high | $113.76 (Oct 2025) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in RYTM would be worth today ›No. Rhythm Pharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Rhythm Pharmaceuticals, Inc. stock trades on NASDAQ under the ticker symbol RYTM.
Rhythm Pharmaceuticals, Inc. is part of the Healthcare sector.
Rhythm Pharmaceuticals, Inc. has a market cap of 7.57B USD, based on the latest quote.
Rhythm Pharmaceuticals, Inc. is expected to report earnings around Nov 3, 2026. That date is an estimate and has not been confirmed by the company.
